
AZothBio (에이조스바이오)
AZothBio (에이조스바이오)
Claim
Based on the AI-BIO platform has established the new drug development platform for compound screening such as new small molecules, macromolecules such as peptides and proteins, and phenotype-based anticancer compounds, and for predicting the suitability of new drugs. We want to contribute to the advancement of medical care by minimizing the time required to develop new drugs for pharmaceutical companies, bio-ventures, and patients.Based on the AI-BIO platform has established the new drug development platform for compound screenin Show More
Alpha Score
$ 5.85 M
Alpha Score
62.7
Predictions
Overview
Team
Financials
- Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes
0and0